Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

0.3564 (USD) • At close May 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -6.864-7.77-7.253-7.142-7.992-7.414-7.124-9.386-10.177-12.232-13.416-10.535-12.405-9.366-9.685-9.771-7.972-5.131-5.367-4.91-4.692-6.705
Depreciation & Amortization 0.0340.3310.33200.1370.1350.3320.3320.3580.3510.3420.320.3340.3290.1360.1220.0980.070.0640.0520.0230.023
Deferred Income Tax 000000.356-0.214-0.142000000.199-0.3530.1730000-1.041.827
Stock Based Compensation 0.4610.3910.7330.7951.2161.0981.0481.0951.2131.3991.4791.4191.5150.8261.7361.7461.3490.3540.7810.1630.1940.391
Change In Working Capital 00.251.3420.085-1.427-0.40.979-1.715-3.1940.6554.545-3.525-0.6670.0932.5881.681-4.2452.023-1.2781.384-2.5261.621
Accounts Receivables 0000000000000000000000
Change In Inventory 0000000000000000000000
Change In Accounts Payables 1.1090-0.32400.306-0.7810.471-2.2630.2422.0172.234-2.6772.644-1.0180.740.732-1.882.812-2.5241.151-1.1041.624
Other Working Capital 00.251.6660.085-1.7330.3810.5080.548-3.436-1.3622.311-0.848-3.3111.1111.8480.949-2.365-0.7891.2460.233-1.422-0.003
Other Non Cash Items 01.006-0.6240.471.6340.0620.3180.3530.0640.2530.2470.4220.4730.0510.0010.0020.0030.0040.0020.5441.5811.192
Operating Cash Flow -7.094-5.792-5.47-5.792-7.616-6.163-4.661-9.463-11.736-9.574-6.803-11.899-10.75-7.868-5.577-6.047-10.767-2.68-5.798-2.767-6.46-1.651
Investing Activities:
Investments In Property Plant And Equipment 000-0.109-0.03700-0.029-0.151-0.071-0.25-0.052-0.019-0.535-0.388-0.616-0.487-0.316-0.836-0.002-0.052-0.044
Acquisitions Net 00000-0.16600.157000.015-0.0130-120.88600000-000
Purchases Of Investments -6.349-17.766-8.836-11.734-6.259-2.613-8.688-0.002-9.84618.148-21.748-35.252-8.017-9.853-26.671-147.145000000
Sales Maturities Of Investments 13.514.61521.7518.7512.06610.8751719.412.3-2.10530.548.520.2291626.2590000000
Other Investing Activites 0.040000.0060.1660.0080.020.0090.0710.0090.0130.012120.88626.577-147.145000-0.19700
Investing Cash Flow 7.191-3.15112.9146.9075.778.2628.31219.5262.31216.0438.51713.19612.1935.612-0.482-147.761-0.487-0.316-0.836-0.199-0.052-0.044
Financing Activities:
Debt Repayment 0-0.207-0.204-0.201-0.199-0.196-0.19-0.189-0.186-0.177-0.163-0.156-0.133-0.227-0.007-0.011-0.01-0.01-0.010.556-0.011.492
Common Stock Issued 0000000000.238000.2380.029023.491140.5940.5410000
Common Stock Repurchased 0000-0-0.252-2.344-7.78800000000000000
Dividends Paid 0000000000000000000000
Other Financing Activities -0.2140.01300.021-0.010.01700.031-0.0760.05300.0370.2520.1090023.49215.8698.491010.5670.154
Financing Cash Flow -0.214-0.194-0.204-0.18-0.209-0.431-2.534-7.946-0.262-0.124-0.163-0.1190.119-0-0-00.16415.8598.4810.55610.5571.646
Other Information:
Effect Of Forex Changes On Cash 0000011.5030-11.50300000000000000
Net Change In Cash -0.117-9.1377.240.935-2.0551.6681.1172.117-9.6866.3451.5511.1781.562-2.374-6.066-153.819152.82212.8631.847-2.414.045-0.049
Cash At End Of Period 9.8779.99419.13111.89110.95613.01111.34310.2268.10917.79511.459.8998.7217.1599.53315.599169.41816.5963.7331.8864.2960.251